{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:25:31Z","timestamp":1790702731122,"version":"4.1.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T00:00:00Z","timestamp":1513209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["106TMU-TMUH-23"],"award-info":[{"award-number":["106TMU-TMUH-23"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0188975","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T13:42:42Z","timestamp":1513258962000},"page":"e0188975","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"12","author":[{"given":"Yen-Chung","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jheng-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai-Szu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Chou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Chi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8244-2846","authenticated-orcid":true,"given":"Yi-No","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,12,14]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"PA James","year":"2014","journal-title":"Jama"},{"issue":"22","key":"ref2","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A Randomized Trial of Intensive versus Standard Blood-Pressure Control","volume":"373","author":"JT Wright Jr","year":"2015","journal-title":"The New England journal of medicine"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1620\/tjem.238.17","article-title":"Renin-Angiotensin-Aldosterone System Blockade in Critically Ill Patients Is Associated with Increased Risk for Acute Kidney Injury","volume":"238","author":"HJ Lim","year":"2016","journal-title":"The Tohoku journal of experimental medicine"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.ajkd.2013.03.018","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. American journal of kidney diseases: the official journal of the","volume":"62","author":"SJ Taler","year":"2013","journal-title":"National Kidney Foundation"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/hr.2015.69","article-title":"Effect of N- and T-type calcium channel blocker on proteinuria, blood pressure and kidney function in hypertensive patients: a meta-analysis","volume":"38","author":"N Thamcharoen","year":"2015","journal-title":"Hypertension research: official journal of the Japanese Society of Hypertension"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS medicine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"SP Hozo","year":"2005","journal-title":"BMC medical research methodology"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/sim.1188","article-title":"Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes","volume":"21","author":"JJ Deeks","year":"2002","journal-title":"Stat Med"},{"issue":"1","key":"ref9","first-page":"59","article-title":"Odds Ratio, Hazard Ratio and Relative Risk","volume":"13","author":"J Stare","year":"2016","journal-title":"Metodoloski Zvezki"},{"issue":"7414","key":"ref10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"BMJ"},{"issue":"21","key":"ref11","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial","volume":"285","author":"LY Agodoa","year":"2001","journal-title":"Jama"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.ajkd.2004.10.019","article-title":"Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy","volume":"45","author":"RC Atkins","year":"2005","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.7326\/0003-4819-138-7-200304010-00010","article-title":"Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy","volume":"138","author":"T Berl","year":"2003","journal-title":"Annals of internal medicine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/00004872-199715120-00093","article-title":"The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to moderate renal failure","volume":"15","author":"C Campo","year":"1997","journal-title":"Journal of Hypertension"},{"issue":"2","key":"ref15","first-page":"261","article-title":"Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril","volume":"17","author":"L Del Vecchio","year":"2004","journal-title":"Journal of Nephrology"},{"issue":"83","key":"ref16","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1046\/j.1523-1755.63.s83.15.x","article-title":"ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial","author":"JG Douglas","year":"2003","journal-title":"Kidney international Supplement"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.clinthera.2008.03.006","article-title":"The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: A 3-year, randomized, multicenter, double-blind, placebo-controlled study","volume":"30","author":"VLM Esnault","year":"2008","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"ref18","first-page":"131","article-title":"Comparative effects of ramipril and nitrendipine on albuminuria in hypertensive patients with non-insulin-dependent diabetes mellitus and impaired renal function","volume":"9","author":"R Fogari","year":"1995","journal-title":"Journal of human hypertension"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/ndt\/gfk058","article-title":"A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period","volume":"21","author":"RN Formica Jr.","year":"2006","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"key":"ref20","first-page":"1245","article-title":"Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency","volume":"50","author":"S Giri","year":"2002","journal-title":"The Journal of the Association of Physicians of India"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10157-003-0241-3","article-title":"Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study","volume":"7","author":"Y Iino","year":"2003","journal-title":"Clinical and experimental nephrology"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1291\/hypres.27.21","article-title":"Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension\u2014a report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) study","volume":"27","author":"Y Iino","year":"2004","journal-title":"Hypertension research: official journal of the Japanese Society of Hypertension"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"EJ Lewis","year":"2001","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"c139","DOI":"10.1159\/000086714","article-title":"A prospective open-label randomised trial of quinapril and\/or amlodipine in progressive non-diabetic renal failure","volume":"101","author":"MS MacGregor","year":"2005","journal-title":"Nephron Clinical practice"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00004872-200110000-00023","article-title":"A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease","volume":"19","author":"R Marin","year":"2001","journal-title":"Journal of Hypertension"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1291\/hypres.31.841","article-title":"Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency","volume":"31","author":"T Nakamura","year":"2008","journal-title":"Hypertension research: official journal of the Japanese Society of Hypertension"},{"issue":"5","key":"ref27","first-page":"375","article-title":"A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension","volume":"55","author":"LJ Petersen","year":"2001","journal-title":"Clin Nephrol"},{"issue":"5","key":"ref28","first-page":"310","article-title":"Proteinuria in mild to moderate hypertension: Results of the VA cooperative study of six antihypertensive agents and placebo","volume":"47","author":"RA Preston","year":"1997","journal-title":"Clinical Nephrology"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2215\/CJN.07800811","article-title":"Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR","volume":"7","author":"M Rahman","year":"2012","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archinte.165.8.936","article-title":"Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"165","author":"M Rahman","year":"2005","journal-title":"Arch Intern Med"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.7326\/0003-4819-144-3-200602070-00005","article-title":"Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate","volume":"144","author":"M Rahman","year":"2006","journal-title":"Annals of internal medicine"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1291\/hypres.24.377","article-title":"Cilnidipine is as effective as benazepril for control of blood pressure and proteinuria in hypertensive patients with benign nephrosclerosis","volume":"24","author":"GW Rose","year":"2001","journal-title":"Hypertension Research"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000049060","article-title":"Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease","volume":"90","author":"Y Shibasaki","year":"2002","journal-title":"Nephron"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1291\/hypres.28.787","article-title":"Impact of the angiotensin II receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal disease: assessment by ultrasonic integrated backscatter and biochemical markers","volume":"28","author":"Y Shibasaki","year":"2005","journal-title":"Hypertension research: official journal of the Japanese Society of Hypertension"},{"issue":"17","key":"ref35","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1001\/archinternmed.2009.284","article-title":"Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy","volume":"169","author":"JM Weinberg","year":"2009","journal-title":"Arch Intern Med"},{"issue":"19","key":"ref36","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"JT Wright Jr.","year":"2002","journal-title":"Jama"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3109\/0886022X.2010.502276","article-title":"Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patients","volume":"32","author":"R Yilmaz","year":"2010","journal-title":"Renal failure"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/ki.1992.309","article-title":"Long-term comparison between captopril and nifedipine in the progression of renal insufficiency","volume":"42","author":"P Zucchelli","year":"1992","journal-title":"Kidney Int"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0895-7061(00)01317-0","article-title":"Laragh's lessons in pathophysiology and clinical pearls for treating hypertension","volume":"14","author":"J Laragh","year":"2001","journal-title":"American journal of hypertension"},{"issue":"16","key":"ref40","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ehj.2004.06.003","article-title":"Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology","volume":"25","author":"J Lopez-Sendon","year":"2004","journal-title":"Eur Heart J"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.CIR.95.5.1115","article-title":"Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans","volume":"95","author":"B Hornig","year":"1997","journal-title":"Circulation"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00877755","article-title":""Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy","volume":"9","author":"B Pitt","year":"1995","journal-title":"Cardiovascular drugs and therapy"},{"issue":"9230","key":"ref43","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(00)02596-4","article-title":"Vasopeptidase inhibition and angio-oedema","volume":"356","author":"FH Messerli","year":"2000","journal-title":"Lancet (London, England)"},{"issue":"19","key":"ref44","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","article-title":"Calcium-antagonist drugs","volume":"341","author":"DR Abernethy","year":"1999","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0895-7061(94)00247-9","article-title":"Calcium channel blockers. Is it time to split the lump?","volume":"8","author":"BJ Materson","year":"1995","journal-title":"American journal of hypertension"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1751-7176.2011.00513.x","article-title":"Calcium channel blockers","volume":"13","author":"WJ Elliott","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000072054","article-title":"Role of actions of calcium antagonists on efferent arterioles\u2014with special references to glomerular hypertension","volume":"23","author":"K Hayashi","year":"2003","journal-title":"American journal of nephrology"},{"issue":"6","key":"ref48","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/0886022X.2016.1165065","article-title":"Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis","volume":"38","author":"HJ Zhao","year":"2016","journal-title":"Renal failure"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00038-008-7068-3","article-title":"When to use the odds ratio or the relative risk?","volume":"53","author":"CO Schmidt","year":"2008","journal-title":"International journal of public health"},{"issue":"23","key":"ref50","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"K Jamerson","year":"2008","journal-title":"The New England journal of medicine"},{"issue":"9","key":"ref51","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/HJH.0000000000000277","article-title":"Have we attained the right control of hypertension? Consequences of the 2013 European Society of Hypertension\/European Society of Cardiology and Eighth Joint National Committee recommendations","volume":"32","author":"G Mancia","year":"2014","journal-title":"J Hypertens"},{"issue":"10","key":"ref52","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1751-7176.2007.tb00006.x","article-title":"Hypertension and coronary artery disease: a summary of the American Heart Association scientific statement","volume":"9","author":"C Rosendorff","year":"2007","journal-title":"J Clin Hypertens (Greenwich)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0188975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T09:07:49Z","timestamp":1540199269000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0188975"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,14]]},"references-count":52,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0188975","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,14]]}}}